These aberrantly expressed glycoproteins, including MUC1, MUC4, and MUC13 play important roles in tumor progression and treatment and are commonly referred to as tumor-related glycoproteins (Dhanisha et al., 2018). Here, MUC1 is linked to neoplasm.